**
Recent analyses reveal that the rate of abortions in the United States remains consistent, despite the imposition of strict bans in various states. This stability is largely attributed to the growing availability of telehealth services and the option of mail-order medication, enabling individuals to access reproductive healthcare more conveniently.
Abortion Rates Hold Steady
According to a report from the Guttmacher Institute, the number of abortions performed in the US saw a slight increase from 1.124 million in 2024 to 1.126 million in 2025. This trend persists even as the regulatory landscape surrounding abortion care becomes increasingly complex, with some states enacting total or partial bans. The report shows a noteworthy shift in how individuals are obtaining abortions, with a marked decline in travel across state lines for care, in favour of telehealth options.
The ongoing review by US regulatory officials regarding the dispensing of mifepristone, a key abortion medication, has been postponed until after the midterm elections. This delay comes amidst considerable public support for abortion rights across the nation.
Shift Towards Telehealth
One of the significant findings of the report is the rise in telehealth consultations, particularly for patients residing in states with stringent abortion bans. Medical professionals in states such as New York and Massachusetts, which have enacted protective shield laws, are now able to prescribe medications remotely to individuals in states like Texas and Alabama, where access is severely restricted.
Joanne Rosen, a professor at the Johns Hopkins School of Public Health, highlighted the crucial role of these shield laws. “They allow individuals to circumvent the restrictions imposed by their own state’s abortion ban,” she explained. This legal framework not only enhances affordability and accessibility but also safeguards providers from potential legal repercussions.
In 2025, approximately 142,000 individuals travelled out of state for abortion services, a decrease from 154,000 in 2024. Notably, nearly half of those travelling for abortions were residents of states imposing total bans. The data indicates a significant reduction in travel among these individuals, with 12,000 fewer people seeking care outside their home states compared to the previous year. However, the number of those travelling remains more than twice the figures recorded prior to the Dobbs decision that triggered many of these restrictions.
The Role of Telehealth in Accessing Care
The increase in telehealth consultations has been particularly significant in states with abortion bans. Isaac Maddow-Zimet, a data scientist at the Guttmacher Institute and co-author of the report, explained that telehealth eliminates the need for patients to travel long distances for care. “This shift is not surprising, but it marks the first time we have been able to document the change in real time,” he noted.
Maddow-Zimet identified two predominant trends: the growing difficulty and expense associated with travel, coupled with the increasing availability of telehealth services. “Patients are now required to journey hundreds of miles, often crossing several state lines, to obtain care,” he commented. While in-person visits remain essential for some, particularly those later in pregnancy, telehealth offers a vital alternative for many others.
Patients in states without outright bans but with stringent in-person dispensing requirements are increasingly opting for telehealth services as well. The FDA has approved mifepristone for use up to ten weeks of pregnancy, with evidence supporting its effectiveness even beyond that timeframe.
Legal Challenges and the Future of Abortion Access
Despite the protections offered by shield laws, these legal frameworks are facing scrutiny and challenges in court. Texas has initiated civil actions against healthcare providers in New York and California, questioning the applicability of these laws. The outcomes of such legal battles remain uncertain.
The FDA is also contemplating new restrictions on telehealth prescriptions for mifepristone, despite its established safety profile. Rosen noted that various states have initiated lawsuits against federal initiatives, arguing both safety concerns and violations of state sovereignty.
As the legal landscape continues to evolve, individuals seeking abortion care often find themselves navigating a complex patchwork of state laws. Maddow-Zimet remarked that many individuals remain unaware of their state’s abortion regulations until they require care, a situation that has only become more convoluted in the current climate.
Why it Matters
The ongoing discourse surrounding abortion access in the United States underscores a critical intersection of public health and legal rights. As telehealth options expand, they provide a necessary lifeline for many individuals seeking reproductive healthcare amidst restrictive state laws. The evolving landscape not only reflects the resilience of those advocating for reproductive rights but also highlights the urgent need for accessible healthcare solutions in a fragmented policy environment. As the situation develops, understanding these dynamics will be essential in promoting equitable access to healthcare for all.